EUVIMEDEUVIMED entdecken
EditorialKommentar

Surgical vs Nonsurgical Management for Pituitary Apoplexy

Julio Abucham iD

The Journal of Clinical Endocrinology & Metabolism · 2024

DOI: 10.1210/clinem/dgad691 ↗

Kurz gefasst

Editorial in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2024. Verfasst von Julio Abucham. Beteiligte Einrichtung: Neuroendocrine Unit, Division of Endocrinology and Metabolism, Department of Medicine, Escola Paulista de Medicina-Universidade Federal de São Paulo,…. Hauptthemen laut MEDLINE: Pituitary Apoplexy. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pituitary apoplexy (PA) is a clinical condition caused by bleeding and/or infarction within a pituitary tumor resulting in sudden tumor enlargement. Compression of the pituitary gland and surrounding structures determines variable clinical presentations that may include hypopituitarism, headache, visual deficit, ocular palsy, and consciousness impairment. Adrenocorticotropic insufficiency can cause hypotension, nausea, vomiting, and hypoglycemia. Meningeal irritation may develop if bleeding reaches the cerebrospinal fluid. As most patients with PA do not have a previous diagnosis of their pituitary tumor, other diagnoses must be considered: subarachnoid hemorrhage, cerebrovascular accident, meningitis, and brain tumors. Brain and pituitary computerized tomography and/or magnetic resonance are essential for the diagnosis. Up to 25% of pituitary adenomas show areas of bleeding, representing asymptomatic PA (1). Nearly 3 decades ago, PA was considered an emergency warranting prompt surgical intervention. Nonetheless, the idea that its treatment could be conservative had already been raised in case series/reports. At that time, in our practice at a tertiary medical center, we noted that patients with PA on glucocorticoid and supportive measures did well for many days while awaiting surgery. Those observations inspired a prospective study comparing conservative vs surgical treatments in PA (2). In that trial, patients underwent surgery if they did not improve during the first week of clinical treatment. Both treatments were successful, safe, and comparable. That “proof of concept” study set the stage for more flexibility in PA treatment thereafter.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pituitary ApoplexyHumansPituitary NeoplasmsConservative TreatmentNeurosurgical ProceduresTreatment Outcome

Stichwörter der Autor:innen

conservative managementpituitary apoplexypituitary apoplexy managementpituitary apoplexy treatmenttranssphenoidal surgery

Autor:innen und Institutionen

  • Neuroendocrine Unit, Division of Endocrinology and Metabolism, Department of Medicine, Escola Paulista de Medicina-Universidade Federal de São Paulo, São Paulo, SP 04022-001, Brazil.

ORCID-Profile: Julio Abucham

Zitieren

APA

Abucham, J. (2024). Surgical vs Nonsurgical Management for Pituitary Apoplexy. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad691

Vancouver

Abucham J. Surgical vs Nonsurgical Management for Pituitary Apoplexy. The Journal of Clinical Endocrinology & Metabolism. 2024. doi:10.1210/clinem/dgad691

BibTeX
@article{Abucham2024,
  author = {Abucham, Julio},
  title = {Surgical vs Nonsurgical Management for Pituitary Apoplexy},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2024},
  doi = {10.1210/clinem/dgad691}
}
Kostenlos starten →